NASDAQ:CNSY
Cerenome, Inc.
Cerenome, Inc.'s revenue fell 10.5% in fiscal 2025 to $5.2M while operating margin fell to −293.5%, its lowest in 3 years. Free cash flow was −$20.8M, −399.8% of revenue, and the diluted share count rose 910.3%.Summary generated from Cerenome, Inc.'s SEC filings. Latest annual report filed Mar 12, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$5.2M
Revenue growth−10.5%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating margin−293.5%
Net margin−429.4%
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flow−$20.8M
FCF margin−399.8%
Share count change+910.3%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | 5 | 6 | 5 |
| Operating income | −12 | −20 | −13 | −15 | −15 |
| Net income | −13 | −20 | −13 | −13 | −22 |
| Free cash flow | n/a | n/a | −13 | −11 | −21 |
Recent filings
- 8-KOther events
Oct 2, 2026 - 4Insider transaction report
Oct 1, 2026 - 4Insider transaction report
Oct 1, 2026 - 8-KEntry into a material agreement
Sep 10, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 14, 2026 - 8-KResults of operations and financial condition
Aug 14, 2026 - 8-KAmendment to articles or bylaws
Aug 4, 2026 - 8-KEntry into a material agreement
Jun 5, 2026